The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial by Jaume Mora, Godfrey C. F. Chan, Daniel A. Morgenstern, Loredana Amoroso, Karsten Nysom, Jörg Faber, Arthur Wingerter, Melissa K. Bear, Alba Rubio-San-Simon, Blanca Martínez de Las Heras, Karen Tornøe, Maria Düring, Brian H. Kushner

Get full text

Corrigendum to “European standard clinical practice recommendations for newly diagnosed ependymoma of childhood and adolescence” [EJC Paediatr. Oncol. 5 (2025) 100227] by Alba Rubio-San-Simón, Timothy A. Ritzmann, Denise Obrecht-Sturm, Martin Benesch, Beate Timmermann, Pierre Leblond, John-Paul Kilday, Geraldina Poggi, Nicola Thorp, Maura Massimino, Marie-Lise van Veelen, Martin Schuhmann, Ulrich-Wilhelm Thomale, Stephan Tippelt, Ulrich Schüller, Stefan Rutkowski, Richard G. Grundy, Stephanie Bolle, Ana Fernández-Teijeiro, Kristian W. Pajtler

Get full text

European standard clinical practice recommendations for newly diagnosed ependymoma of childhood and adolescence by Alba Rubio-San-Simón, Timothy A. Ritzmann, Denise Obrecht-Sturm, Martin Benesch, Beate Timmermann, Pierre Leblond, John-Paul Kilday, Geraldina Poggi, Nicola Thorp, Maura Massimino, Marie-Lise van Veelen, Martin Schuhmann, Ulrich-Wilhelm Thomale, Stephan Tippelt, Ulrich Schüller, Stefan Rutkowski, Richard G. Grundy, Stephanie Bolle, Ana Fernández-Teijeiro, Kristian W. Pajtler

Get full text